Skip to main content
. 2018 Nov 27;9(3):526–536. doi: 10.1016/j.apsb.2018.11.004

Figure 6.

Fig. 6

Liver fibrosis and cirrhosis are characterized with elevated BAs and hepatocyte apoptosis. Serum from liver fibrotic patients (n = 20), cirrhotic patients (n = 30) as well as healthy donors (n = 20) were collected. Serum total BA levels (A) and BA profiles as analyzed (B). Hepatocyte apoptosis was assessed by TUNEL staining of liver biopsy (C) and serum CK-18 (M30) levels (D). Results are mean ± SD, *P < 0.05, **P < 0.01, ***P < 0.001.